Back
Abercrombie & Fitch Vs. Monopar Therapeutics Industry Stock Comparison
Buy
54
ANF
Abercrombie & Fitch
Last Price:
$158.86
Seasonality Move:
14.5%
Sell
39
MNPR
Monopar Therapeutics
Last Price:
$23.42
Seasonality Move:
-3.22%
Buy
54
Abercrombie & Fitch (ANF)
is a Buy
Is Abercrombie & Fitch a Buy, Sell or Hold?
-
The current Abercrombie & Fitch [ANF] share price is $158.92. The Score for ANF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
ANF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $22.98. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANF Stock Price Chart
What is Abercrombie & Fitch's stock price today?
-
The Abercrombie & Fitch share price today is $158.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANF is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $22.98The current trend is relatively stagnant and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 58.88 | Buy |
Chaikin Money Flow: | 1026625 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (143.53 - 156.61) | Buy |
Bollinger Bands (100): | (136.4 - 156.42) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 50.47 | Buy |
Chaikin Money Flow: | 21142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.53 - 26.33) | Sell |
Bollinger Bands (100): | (3.23 - 21.41) | Buy |
ANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 153.82 | Buy |
20-day SMA: | 148.99 | Buy |
50-day SMA: | 145.69 | Buy |
200-day SMA: | 147 | Buy |
8-day EMA: | 153.68 | Buy |
20-day EMA: | 151 | Buy |
50-day EMA: | 148.24 | Buy |
200-day EMA: | 138.41 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.37 | Sell |
20-day SMA: | 24.26 | Sell |
50-day SMA: | 20.72 | Buy |
200-day SMA: | 7.9 | Buy |
8-day EMA: | 23.47 | Sell |
20-day EMA: | 23.45 | Sell |
50-day EMA: | 19.94 | Buy |
200-day EMA: | 10.64 | Buy |
Abercrombie & Fitch Earnings Growth & ANF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $1.14 per share, an increase this year of $4.51 per share, and an increase next year of $0.76 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.91 per share, and an increase next year of $2.15 per share.
Abercrombie & Fitch Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |